Skip to main content

Table 3 Comparison of the PET/CT results at different PSA levels

From: Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence

 

PSA ≥5 ng/ml (n = 19)

PSA ≥2- < 5 ng/ml (n = 8)

PSA ≥1- < 2 ng/ml (n = 12)

PSA <1 ng/ml (n = 10)

True-positive

15/19 (78.9%)

4/8 (50.0%)

4/12 (33.3%)

0

False-positive

3/19 (15.8%)

2/8 (25.0%)

6/12 (50.0%)

7/10 (70.0%)

True-negative

0

0

2/12 (16.7%)

2/10 (20.0%)

False-negative

1/19 (5.3%)

2/8 (25.0%)

0

1/10 (10.0%)

Specificity

-

-

25.0%

22.2%

Sensitivity

93.8%

66.7%

100.0%

-